M. Tütüncü Et Al. , "mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?," Multiple Sclerosis and Related Disorders , vol.75, 2023
Tütüncü, M. Et Al. 2023. mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?. Multiple Sclerosis and Related Disorders , vol.75 .
Tütüncü, M., Demir, S., Arslan, G., Dinç, Ö., Şen, S., GÜNDÜZ, T., ... Uzunköprü, C.(2023). mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?. Multiple Sclerosis and Related Disorders , vol.75.
Tütüncü, Melih Et Al. "mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?," Multiple Sclerosis and Related Disorders , vol.75, 2023
Tütüncü, Melih Et Al. "mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?." Multiple Sclerosis and Related Disorders , vol.75, 2023
Tütüncü, M. Et Al. (2023) . "mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?." Multiple Sclerosis and Related Disorders , vol.75.
@article{article, author={Melih Tütüncü Et Al. }, title={mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: Humoral responses and protectivity—Does it matter?}, journal={Multiple Sclerosis and Related Disorders}, year=2023}